AUTHOR CORRECTION
Volume 65, no. 7, e00316-21, 2021, https://doi.org/10.1128/AAC.00316-21.
Page 5, Table 2: For the compound RV40, the lung: plasma Cmax ratio should read 480, not 690 as listed.
. 2022 Oct 12;66(11):e01256-22. doi: 10.1128/aac.01256-22
Correction for Plaunt et al., “Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections”
Adam J Plaunt
, Sasha J Rose
, Jeong Yeon Kang
, Kuan-Ju Chen
, Daniel LaSala
, Ryan P Heckler
, Arielle Dorfman
, Barrett T Smith
, Donald Chun
, Veronica Viramontes
, Antonio Macaluso
, Zhili Li
, Yuchen Zhou
, Lilly Mark
, Jessica Basso
, Franziska G Leifer
, Michel R Corboz
, Richard W Chapman
, David Cipolla
, Walter R Perkins
, Vladimir S Malinin
, Donna M Konicek
✉
Adam J Plaunt
Find articles by Adam J Plaunt
Sasha J Rose
Find articles by Sasha J Rose
Jeong Yeon Kang
Find articles by Jeong Yeon Kang
Kuan-Ju Chen
Find articles by Kuan-Ju Chen
Daniel LaSala
Find articles by Daniel LaSala
Ryan P Heckler
Find articles by Ryan P Heckler
Arielle Dorfman
Find articles by Arielle Dorfman
Barrett T Smith
Find articles by Barrett T Smith
Donald Chun
Find articles by Donald Chun
Veronica Viramontes
Find articles by Veronica Viramontes
Antonio Macaluso
Find articles by Antonio Macaluso
Zhili Li
Find articles by Zhili Li
Yuchen Zhou
Find articles by Yuchen Zhou
Lilly Mark
Find articles by Lilly Mark
Jessica Basso
Find articles by Jessica Basso
Franziska G Leifer
Find articles by Franziska G Leifer
Michel R Corboz
Find articles by Michel R Corboz
Richard W Chapman
Find articles by Richard W Chapman
David Cipolla
Find articles by David Cipolla
Walter R Perkins
Find articles by Walter R Perkins
Vladimir S Malinin
Find articles by Vladimir S Malinin
Donna M Konicek
Find articles by Donna M Konicek
✉
Corresponding author.
Collection date 2022 Nov.
PMCID: PMC9664855 PMID: 36222535
This corrects the article "Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections" in volume 65, e00316-21.